This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Reneuron, Inc.. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Guildford, GB (2015 - 2016)
- Surrey, GB (2016)
Company Filing History:
Years Active: 2015-2016
Title: The Innovative Contributions of Erik Miljan
Introduction
Erik Miljan is a notable inventor based in Guildford, GB, recognized for his significant contributions to medical technology. With a total of three patents to his name, Miljan has focused on advancing treatments for critical health conditions.
Latest Patents
Miljan's latest patents include groundbreaking inventions aimed at improving patient care. One of his notable inventions is a treatment for limb ischemia, which utilizes neural stem cells to create a medicament for patients suffering from peripheral arterial disease. This invention is particularly effective for treating limb ischemia or Buerger's disease. Another significant patent involves cellular compositions for therapeutic use, providing a composition that can be formulated for cryopreservation and direct administration to patients.
Career Highlights
Erik Miljan has made substantial strides in the field of medical research and innovation. His work has been instrumental in developing new therapies that address complex medical conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Miljan has collaborated with esteemed colleagues, including John Sinden and Paolo Madeddu, to further enhance the impact of his inventions. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.
Conclusion
Erik Miljan's contributions to medical technology through his patents reflect his dedication to advancing healthcare solutions. His innovative work continues to pave the way for new treatments that can significantly improve the quality of life for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile